Preterm Birth Patients Sought By US FDA As Meeting On Treatment Development Looms

 
• By Derrick Gingery
  
preterm birth
The FDA/Duke-Margolis meeting on preterm birth drug development is scheduled for late January. • Source: Shutterstock

More from R&D

More from Conferences